Review

Conjugated linoleic acid modulation of risk factors associated with atherosclerosis

Yukiko K Nakamura^1,2 , Nichole Flintoff-Dye¹ and Stanley T Omaye^1,2

¹Environmental Sciences Graduate Program, University of Nevada, Reno 89557, USA

²Department of Nutrition, University of Nevada, Reno 89557, USA

author email corresponding author email

Nutrition & Metabolism 2008, 5:22doi:10.1186/1743-7075-5-22

Published:	21 August 2008

Abstract

Conjugated linoleic acid (CLA) has been the subject of extensive investigation regarding its possible benefits on a variety of human diseases. In some animal studies, CLA has been shown to have a beneficial effect on sclerotic lesions associated with atherosclerosis, be a possible anti-carcinogen, increase feed efficiency, and act as a lean body mass supplement. However, the results have been inconsistent, and the effects of CLA on atherogenesis appear to be dose-, isomer-, tissue-, and species-specific. Similarly, CLA trials in humans have resulted in conflicting findings. Both the human and animal study results may be attributed to contrasting doses of CLA, isomers, the coexistence of other dietary fatty acids, length of study, and inter-and/or intra-species diversities. Recent research advances have suggested the importance of CLA isomers in modulating gene expression involved in oxidative damage, fatty acid metabolism, immune/inflammatory responses, and ultimately atherosclerosis. Although the possible mechanisms of action of CLA have been suggested, they have yet to be determined.